bucladesine and Myocardial Infarction
bucladesine has been researched along with Myocardial Infarction in 7 studies
Research
Studies (7)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Harada, S; Hisatome, I; Miyagawa, S; Morikawa, K; Nakamura, Y; Ninomiya, H; Nishimura, M; Ogino, K; Otsuki, Y; Sawa, Y; Yamamoto, Y | 1 |
| Ban, M; Kanayama, H; Ogawa, K; Ukai, M | 1 |
| Cove, CJ; Hood, WB; Stuver, TP | 1 |
| Brenner, S; Döcke, WD; Oppert, M; Platzer, C; Prösch, S; Reinke, P; Riese, U; Volk, HD | 1 |
| Asakura, M; Asanuma, H; Fukushima, T; Hori, M; Kitakaze, M; Kuzuya, T; Liao, Y; Mori, H; Node, K; Ogai, A; Ogita, H; Papst, PJ; Sakata, Y; Sanada, S; Shinozaki, Y; Takashima, S; Terada, N; Yamada, J | 1 |
| Lubbe, WF; Nathan, D; Opie, LH | 1 |
| Kato, T; Sone, T; Yamamoto, M | 1 |
Reviews
1 review(s) available for bucladesine and Myocardial Infarction
| Article | Year |
|---|---|
Biochemical aspects of arrhythmogenesis and ventricular fibrillation.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bucladesine; Catecholamines; Cyclic AMP; Fatty Acids, Nonesterified; Glycolysis; Humans; Hyperkalemia; Lactates; Membrane Potentials; Myocardial Infarction; Myocardium; Potassium; Purkinje Fibers; Theophylline; Ventricular Fibrillation | 1979 |
Other Studies
6 other study(ies) available for bucladesine and Myocardial Infarction
| Article | Year |
|---|---|
Adipose stem cell sheets improved cardiac function in the rat myocardial infarction, but did not alter cardiac contractile responses to β-adrenergic stimulation.
Topics: Adipocytes; Animals; Atrial Natriuretic Factor; Atrial Remodeling; Bucladesine; Cardiomegaly; Cell Differentiation; Diastole; Fibroblast Growth Factors; Hepatocyte Growth Factor; Isoproterenol; Male; Myoblasts, Skeletal; Myocardial Contraction; Myocardial Infarction; Myocardium; Organ Culture Techniques; Paracrine Communication; Pyridazines; Rats; Rats, Inbred Lew; Stem Cell Transplantation; Stem Cells; Systole; Vascular Endothelial Growth Factor A | 2015 |
Myocardial norepinephrine and cyclic amp concentration following myocardial ischemia--relation to ventricular fibrillation and sudden death.
Topics: Animals; Bucladesine; Coronary Disease; Cyclic AMP; Death, Sudden; Dogs; Female; Male; Myocardial Infarction; Myocardium; Norepinephrine; Propranolol; Ventricular Fibrillation | 1983 |
Mechanical abnormalities in the rat ischemic heart failure model which lie downstream to cAMP production.
Topics: Animals; Bucladesine; Cyclic AMP; Disease Models, Animal; Heart Failure; In Vitro Techniques; Male; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Papillary Muscles; Rats; Rats, Sprague-Dawley | 1994 |
Catecholamines induce IL-10 release in patients suffering from acute myocardial infarction by transactivating its promoter in monocytic but not in T-cells.
Topics: Acute Disease; Aged; Bucladesine; Catecholamines; Cell Line; Cyclic AMP Response Element-Binding Protein; Epinephrine; Female; Humans; Interleukin-10; Jurkat Cells; Male; Middle Aged; Monocytes; Myocardial Infarction; Norepinephrine; Promoter Regions, Genetic; Shock, Cardiogenic; T-Lymphocytes; Transcriptional Activation; Transfection | 2000 |
Cardioprotective effect afforded by transient exposure to phosphodiesterase III inhibitors: the role of protein kinase A and p38 mitogen-activated protein kinase.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Blood Flow Velocity; Bucladesine; Calcium-Calmodulin-Dependent Protein Kinases; Cardiovascular Agents; Cyclic AMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 3; Dogs; Enzyme Inhibitors; Flavonoids; Hemodynamics; Imidazoles; Indoles; Isoquinolines; Maleimides; Milrinone; Mitogen-Activated Protein Kinases; Myocardial Infarction; p38 Mitogen-Activated Protein Kinases; Phosphodiesterase Inhibitors; Protein Kinase C; Pyridines; Pyridones; Sulfonamides; Ventricular Fibrillation | 2001 |
[Effects of dibutyryl cyclic AMP on the hemodynamics and myocardial oxygen balance in dogs with experimental myocardial infarction].
Topics: Animals; Bucladesine; Dogs; Hemodynamics; Myocardial Infarction; Myocardium; Oxygen Consumption | 1985 |